发明名称 |
CRYSTALLINE [R-(R*,R*)]-2-(4-FLUOROPHENYL)-beta,delta-DIHYDROXY-5-(1- METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H- PYRROL-1-HEPTANOIC ACID HEMICALCIUM SALT (ATORVASTATIN) |
摘要 |
PROBLEM TO BE SOLVED: To provide the stable form of atorvastation being a medicine for treating hyperlipemia and hypercholesterolemia. SOLUTION: This [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1- methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-heptanoic acid (atorvastatin) in a new crystalline form called form I, form II and form IV or their hydrate characterized by X-ray powder diffraction and/or NMR in a solid state, and the medicine composition comprising the compound are provided.
|
申请公布号 |
JP2003073353(A) |
申请公布日期 |
2003.03.12 |
申请号 |
JP20020008746 |
申请日期 |
2002.01.17 |
申请人 |
WARNER LAMBERT CO |
发明人 |
BRIGGS CHRISTOPHER A;JENNINGS REX ALLEN;WADE ROBERT A;HARASAWA KIKUKO;ICHIKAWA HAYASHI;MINOHARA KAZUO;NAKAGAWA SHINSUKE |
分类号 |
C07D207/34;A61K31/40;A61P3/06;A61P3/14;A61P43/00;C07D;(IPC1-7):C07D207/34 |
主分类号 |
C07D207/34 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|